Ingenol 3-angelate

Ingenol 3-angelate is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 455 references associated with Ingenol 3-angelate in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Ingenol 3-angelate

Download all related citations
Per page 10 20 50 100 | Total 138
Authors Title Published Journal PubMed Link
pmid:
Ogbourne SM et al. Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. 2004 Cancer Res. pmid:15087400
Gillespie SK et al. Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in melanoma cells. 2004 Mol. Cancer Ther. pmid:15634659
Hampson P et al. PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. 2005 Blood pmid:15845901
Cozzi SJ et al. Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway. 2006 Cancer Res. pmid:17047072
Challacombe JM et al. Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate. 2006 J. Immunol. pmid:17114487
pmid:17115221
pmid:17264770
pmid:18265980
Serova M et al. Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells. 2008 Mol. Cancer Ther. pmid:18413805
Benhadji KA et al. Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells. 2008 Br. J. Cancer pmid:19034280
pmid:19178487
pmid:19388934
Ghoul A et al. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells. 2009 Cancer Res. pmid:19417139
pmid:19428919
pmid:19467365
pmid:19922462
Li L et al. The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature. 2010 Cancer Res. pmid:20460505
pmid:20467815
Lee WY et al. Novel antileukemic compound ingenol 3-angelate inhibits T cell apoptosis by activating protein kinase Ctheta. 2010 J. Biol. Chem. pmid:20472553
pmid:20546215
pmid:21325841
pmid:22055282
Cozzi SJ et al. Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches. 2012 J. Invest. Dermatol. pmid:22189786
Fallen RS and Gooderham M Ingenol mebutate: an introduction. 2012 Skin Therapy Lett. pmid:22358305
Lebwohl M et al. Ingenol mebutate gel for actinic keratosis. 2012 N. Engl. J. Med. pmid:22417254
pmid:22538622
pmid:22618984
pmid:22828167
Cozzi SJ et al. Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice. 2013 Arch. Dermatol. Res. pmid:22871992
Doan HQ et al. Ingenol mebutate: potential for further development of cancer immunotherapy. 2012 J Drugs Dermatol pmid:23134979
pmid:23134983
pmid:23228300
pmid:23228305
pmid:23231025
pmid:23302940
pmid:23362492
pmid:23550994
pmid:23553119
pmid:23673300
Song X et al. RasGRPs are targets of the anti-cancer agent ingenol-3-angelate. 2013 PLoS ONE pmid:23991094
Liang X et al. Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer. 2013 Bioorg. Med. Chem. Lett. pmid:23993332
pmid:24005145
pmid:24048430
Edwards SK et al. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma. 2013 BMC Cancer pmid:24131623
pmid:24509965
pmid:24595570
pmid:24742851
pmid:24918567
pmid:25016953

Table of Content